Published in Nat Genet on August 01, 2003
Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med (2009) 6.43
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet (2008) 3.25
Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med (2009) 2.07
Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Transl Med (2004) 2.00
Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis (2005) 1.84
Putting science over supposition in the arena of personalized genomics. Nat Genet (2008) 1.80
Considerations for designing a prototype genetic test for use in translational research. Public Health Genomics (2009) 1.67
Behavior matters. Am J Prev Med (2011) 1.58
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet (2011) 1.57
Genome-based prediction of common diseases: methodological considerations for future research. Genome Med (2009) 1.46
Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases. Am J Hum Genet (2012) 1.30
Do we know enough? A scientific and ethical analysis of the basis for genetic-based personalized nutrition. Genes Nutr (2013) 1.23
Blazing a trail: a public health research agenda in genomics and chronic disease. Prev Chronic Dis (2005) 1.21
Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am J Public Health (2008) 1.15
Being more realistic about the public health impact of genomic medicine. PLoS Med (2010) 1.06
Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiers. BMC Med Genet (2011) 1.04
Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic tests. Soc Sci Med (2009) 0.99
Genomic medicine: considerations for health professionals and the public. Genome Med (2009) 0.95
Genetics, individuality, and medicine in the 21st century. Am J Hum Genet (2004) 0.94
Genotype-phenotype associations: modulation by diet and obesity. Obesity (Silver Spring) (2008) 0.93
Public health genomics: translating obesity genomics research into population health benefits. Obesity (Silver Spring) (2008) 0.90
Genetic susceptibility testing and readiness to control weight: Results from a randomized controlled trial. Obesity (Silver Spring) (2014) 0.88
"Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer. J Genet Couns (2012) 0.87
Genetic test feedback with weight control advice: study protocol for a randomized controlled trial. Trials (2012) 0.86
Why should genomic medicine become more evidence-based? Genomic Med (2007) 0.83
Genetic Factors Are Not the Major Causes of Chronic Diseases. PLoS One (2016) 0.81
Common genetic risk for melanoma encourages preventive behavior change. J Pers Med (2015) 0.81
Public health genomics and genetic test evaluation: the challenge of conducting behavioural research on the utility of lifestyle-genetic tests. J Nutrigenet Nutrigenomics (2008) 0.80
Assessing the social meaning, value and implications of research in genomics. J Epidemiol Community Health (2007) 0.75
Can genomic medicine be applied to the management of essential hypertension? Clin Med Res (2003) 0.75
DNA analysis: what and when to request? Arch Dis Child (2006) 0.75
International network of cancer genome projects. Nature (2010) 20.35
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Letting the genome out of the bottle--will we get our wish? N Engl J Med (2008) 9.10
Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med (2011) 8.48
Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol (2006) 7.66
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA (2008) 5.25
A navigator for human genome epidemiology. Nat Genet (2008) 5.07
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53
Offering individual genetic research results: context matters. Sci Transl Med (2010) 4.51
How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol (2005) 4.46
American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin (2003) 4.43
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 4.22
Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet (2013) 4.06
Can family history be used as a tool for public health and preventive medicine? Genet Med (2002) 3.76
National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health (2012) 3.72
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med (2012) 3.44
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet (2008) 3.25
Recommendations for returning genomic incidental findings? We need to talk! Genet Med (2013) 3.23
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. JAMA (2006) 3.20
ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol (2007) 3.19
What is the clinical utility of genetic testing? Genet Med (2006) 3.01
Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med (2003) 2.99
Improving validation practices in "omics" research. Science (2011) 2.73
Newborn screening technology: proceed with caution. Pediatrics (2006) 2.54
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health (2010) 2.43
Science and regulation. Regulating direct-to-consumer personal genome testing. Science (2010) 2.40
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
The genomic applications in practice and prevention network. Genet Med (2009) 2.39
The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med (2007) 2.34
Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34
Most published research findings are false-but a little replication goes a long way. PLoS Med (2007) 2.26
Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Diabetes Care (2007) 2.22
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
Pharmacogenetic testing: not as simple as it seems. Genet Med (2008) 2.18
Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med (2009) 2.17
DNA banking for epidemiologic studies: a review of current practices. Epidemiology (2002) 2.16
The path from genome-based research to population health: development of an international public health genomics network. Genet Med (2006) 2.15
Invited commentary: genes, environment, and hybrid vigor. Am J Epidemiol (2009) 2.15
The FDA and genomic tests--getting regulation right. N Engl J Med (2015) 2.09
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med (2013) 2.08
Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Am J Epidemiol (2015) 2.04
Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med (2010) 1.98
Next-generation sequencing in the clinic: are we ready? Nat Rev Genet (2012) 1.95
Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet (2003) 1.85
Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis (2005) 1.84
Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A (2008) 1.84
On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction. Epidemiology (2003) 1.82
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med (2011) 1.80
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
From public health emergency to public health service: the implications of evolving criteria for newborn screening panels. Pediatrics (2006) 1.77
Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med (2006) 1.77
GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics (2008) 1.75
The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol (2014) 1.73
"Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev (2013) 1.72
Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet (2011) 1.69
Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm (2015) 1.67
Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol (2006) 1.67
Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med (2006) 1.67
Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak (2010) 1.66
Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet (2009) 1.62
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Researcher perspectives on disclosure of incidental findings in genetic research. J Empir Res Hum Res Ethics (2010) 1.55
Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol (2008) 1.53
Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med (2008) 1.51
Clinical decisions. Screening an asymptomatic person for genetic risk. N Engl J Med (2014) 1.51
Informed Consent in Genome-Scale Research: What Do Prospective Participants Think? AJOB Prim Res (2012) 1.50
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genet Med (2010) 1.47
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer (2008) 1.45
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med (2006) 1.43
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med (2012) 1.39
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting. Genet Med (2011) 1.37
Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med (2011) 1.36
Horizon scanning for new genomic tests. Genet Med (2011) 1.36
Taking family history seriously. Ann Intern Med (2005) 1.36
The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update. Genet Med (2006) 1.35
Personal utility and genomic information: look before you leap. Genet Med (2009) 1.32
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med (2012) 1.32
Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics (2008) 1.31
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst (2010) 1.30
Diverse perceptions of the informed consent process: implications for the recruitment and participation of diverse communities in the National Children's Study. Am J Community Psychol (2012) 1.28
Trends in death associated with pediatric dental sedation and general anesthesia. Paediatr Anaesth (2013) 1.28
Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med (2010) 1.27
Gene expression profiling and breast cancer care: what are the potential benefits and policy implications? Genet Med (2005) 1.27